Rodney W. Lappe
Independent DirectorDr. Rodney W. Lappe, Ph.D. is a Director at Design Therapeutics, Inc. since July 2019 and as a Consultant since November 2023. Dr. Lappe served as Chairman of Mirati Therapeutics, Inc. since July 2013 until June 2016 and served as its Director from June 27, 2012 to April 22, 2019 and served as its Executive Chairman of the Board since June 2016 until February 15, 2019. Since January 2012, Dr. Lappe has served as the Senior Vice President of Tavistock Life Sciences. He served as the Chief Scientific Officer of CovX Research LLC. Dr. Lappe joined CovX in January 2004. From January 2004 to December 2011, he was Group Senior Vice President, Pfizer Worldwide Research and Development at CovX Research LLC. He joined Pfizer with the CovX acquisition in 2008. Dr. Lappe has been responsible for the advancement of large portfolios of drug discovery projects and has promoted multiple therapeutic candidates through pre-clinical and clinical development. From August 2000 to December 2003, Dr. Lappe served as Vice President for cardiovascular and metabolic diseases at Pharmacia Group. From 2000 to 2002, Dr. Lappe, he served as Vice President for cardiovascular and metabolic diseases at Pharmacia where he contributed to the registration of Inspra®. He was also the site leader for Pharmacia in St. Louis. He has been a Director of MethylGene Inc., since June 27, 2012. He served as a Director of Neuren Pharmaceuticals Ltd. until April 2, 2004. Prior to joining Pharmacia, he held positions of increasing responsibility with Wyeth Laboratories, Rorer Central Researh, CIBA Geigy Pharmaceuticals and Searle Pharmaceuticals. He has 23 years of drug discovery experience in the pharmaceutical industry. Dr. Lappe has experience managing pharmaceutical and biotech companies. He has a strong understanding of pharmacology, a clear strategic scientific vision and extensive experience in international drug discovery collaborations. Dr. Lappe received his PhD in Pharmacology from Indiana University and his BA from Blackburn College.
Positions
- Company NameDesign Therapeutics, Inc.Stock CodeDSGNPositionIndependent DirectorColleagues
- PSPratik ShahCo-Founder, President, CEO, Principal Financial Officer & Executive Chairperson
- SJSean JeffriesChief Operating Officer
- CMChris M. StorgardChief Medical Officer
- AZAseem Z. AnsariCo-Founder & Scientific Advisor
- JDJulie D. BurgessChief Accounting Officer
- JPJohn P. SchmidIndependent Director
- JDJustin D. GoverIndependent Director
